Search filters

List of works by Tomasz Switaj

Adamantylsulfanyl- and N-adamantylcarboxamido-derivatives of heterocycles and phenols: synthesis, crystal structure, tumor necrosis factor-alpha production-enhancing properties, and theoretical considerations

scientific article published on 01 October 2004

Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients

scientific article published on 01 December 2012

Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans

scientific article published on 30 March 2011

Antitumor effects of sulindac in ovarian cell cultures

scientific article published in March 2011

Cell-free DNA BRAF V600E measurements during BRAF inhibitor therapy of metastatic melanoma: long-term analysis

scientific article published on 06 February 2020

Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice

scientific article published on 07 November 2003

CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice

scientific article published on June 2004

Cutaneous melanoma – guidelines for diagnostics and therapy in 2016

scientific article published in 2016

Czerniaki skóry — zasady postępowania diagnostyczno-terapeutycznego w 2016 roku

scientific article published on 9 February 2016

Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells

scientific article published on July 2004

Efficacy and safety of ipilimumab therapy in patients with metastatic melanoma: a retrospective multicenter analysis

scientific article published on 28 June 2013

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications

scientific article

High baseline neutrophil-to-lymphocyte ratio predicts worse outcome in patients with metastatic BRAF-positive melanoma treated with BRAF and MEK inhibitors

scientific article published on 01 October 2018

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study.

scientific article

Interleukin 12-based immunotherapy improves the antitumor effectiveness of a low-dose 5-Aza-2'-deoxycitidine treatment in L1210 leukemia and B16F10 melanoma models in mice

scientific article published in August 2003

Long-term results of therapy with sunitinib in metastatic alveolar soft part sarcoma

scientific article

Malignant peripheral nerve sheath tumors - Outcomes and prognostic factors based on the reference center experience

scientific article published on 12 September 2020

Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome.

scientific article

Pigmented/melanocytic malignant perivascular epithelioid cell tumor with TFE3-SFPQ(PSF) rearrangement - a challenging diagnosis of PEComa family of tumors

scientific article published on 01 January 2019

Results of systemic treatment of cutaneous melanoma in inoperable stage III and IV

scientific article

Stimulation of TNF-alpha production by 2-(1-adamantylamino)-6-methylpyridine (AdAMP) - a novel immunomodulator with potential application in tumour immunotherapy.

scientific article

Synthesis and biological properties of S-adamantylated heterocyclic compounds

scientific article published in November 2002

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors-A Sarcoma Reference Center Experience

scientific article published on 29 September 2020

TNF-alpha production-enhancing activity of 2-(1-adamantylamino)-6-methylpyridine (AdAMP) in cultures of human normal and neoplastic cells.

scientific article published on March 2006

Technology evaluation: HYB-2055, Hybridon

scientific article published on 01 August 2005

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma

scientific article published on 28 September 2020

The analysis of 3-year adjuvant therapy with imatinib in patients with high-risk molecular profiled gastrointestinal stromal tumors (GIST) treated in routine practice

scientific article published on 16 August 2020

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST).

scientific article published on 30 December 2017

The clinical prognostic factors and treatment outcomes of adult patients with Ewing sarcoma

scientific article published on 25 July 2020

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

scientific article

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial

scientific article

Treatment Sequencing and Clinical Outcomes in BRAF-Positive and BRAF-Negative Unresectable and Metastatic Melanoma Patients Treated with New Systemic Therapies in Routine Practice

scientific article published on 01 December 2019

Tumor necrosis factor-alpha production-regulating activity of phthalimide derivatives in genetically modified murine melanoma cells B78H1.

scientific article published in May 2003

What are the current outcomes of advanced gastrointestinal stromal tumors: who are the long-term survivors treated initially with imatinib?

scientific article

Paulina is supported by:

About Paulina

Help